https://www.selleckchem.com/products/rmc-4630.html
To assess the outcomes of small choroidal melanoma following iodine-125 episcleral brachytherapy (apical height dose of 85Gy). Patients with small choroidal melanoma that underwent iodine-125 episcleral brachytherapy between January 2004 and December 2017 were reviewed. Inclusion criterion for this study was the COMS small tumour size (tumour apical height of 1.0-2.5 mm and largest basal diameter (LBD) 16.0 mm). Patients that received any form of prior therapy or adjuvant transpupillary thermotherapy were excluded. Outcome measures
Like
Comment
Share
